Friday, 10 February 2012

ASTHMA


Asthma in Children

Asthma in Children

Read about asthma in kids (children). Learn about asthma statistics, diagnosis, symptoms, signs, medications, and what to do when your kid has an asthma attack.
Living with Asthma

Living with Asthma 

Watch this slideshow on asthma and learn about this chronic inflammation disorder of the bronchiole tubes (airways) resulting in breathing difficulty. Find information on causes/triggers, symptoms, prevention and treatment of the disease.
Asthma Myths

Asthma Myths 

There is currently no cure for asthma, and no single exact cause has been identified. Take this slideshow quiz on asthma myths to test your IQ and take an active role in your own health by better understanding this chronic illness.
Topic of the Day

Asthma Medications

Long-Term Control Asthma Medications

Doctors and asthma specialists recognize that asthma has two main components: airway inflammation and acute bronchoconstriction (c.

SEXUALLY TRANSMITTED DISEASE


 Genital Warts (HPV)

Previous.
Genital wart: A wart in the moist skin of the genitals or around theanusGenital warts are due to a human papillomavirus (HPV). The HPVs, including those that cause genital warts, are transmitted throughsexual contact. HPV can also be transmitted from mother to baby during childbirth. Most people infected with HPV have no symptoms, but theseviruses increase a woman's risk for cancer of the cervix. HPV infection is the most common sexually transmitted disease in the US. It is also the leading cause of abnormal PAP smears and pre-cancerous changes of the cervix in women. There is no cure for HPV infection, although anti-viral medications can reduce outbreaks and topical preparations canspeed healing. Once contracted, the virus can stay with a person for life. Also called condyloma acuminatum, condylomata.

DYSMENORRHEA


  • DYSMENORRHEA
  • Menstrual Cramps
    Menstrual cramps (pain in the belly and pelvic area) are experienced by women as a result of menses. Menstrual cramps are not the...Menstrual Cramps (Dysmenorrhea) What are menstrual cramps? How...
  • Menstrual Cramps and Premenstrual Syndrome (PMS) Medication Guide
    Menstrual cramps and premenstrual syndrome (PMS) symptoms include abdominal cramping, bloating, a feeling of fullness, abdominal...Menstrual Cramps and Premenstrual Syndrome (PMS) Medication Guide...
  • Menstruation
    ...or skipped periods. Causes of these problems may be amenorrhea (lack fo a period), menstrual cramps(dysmenorrhea), or abnormal...be involved. It is important to talk to a doctor. Dysmenorrhea...
  • Blood Clots
    Blood clots can occur in the venous and arterial vascular systemBlood clots can form in the heartlegsarteries,veins,...or as abnormal vaginal bleeding (menorrhagia, dysmenorrhea). What are the...
  • Migraine
    Migraine is usually periodic attacks of headaches on one or both sides of the headThese may be accompanied bynauseavomiting,...relief of headache (as well as muscle aches, pains, menstrual cramps ,
  • Insomnia Treatment (Sleep Aids and Stimulants)
    Insomnia is difficulty in falling or staying asleepthe absence of restful sleepor poor quality of sleepInsomnia is asymptom...Caffeine also is present in medications for menstrual cramps,
  • Vaginal Bleeding
    Normal vaginal bleeding (menorrheaoccurs through the process of menstruationAbnormal vaginal bleeding inwomen who are...symptoms including breast tenderness, fluid retention, menstrual cramps,
  • Premenstrual Syndrome (PMS)
    Premenstrual syndrome (PMSis a combination of physical and emotional disturbances that occur after a womanovulates and ends...These are commonly given for menstrual cramps, headaches, and pelvic...
  • Women's Health
    Women's health is an important topic area to guide a woman through the stages of her lifeas well as knowing theconditions and...premenstrual syndrome (PMS) and she may have menstrual cramps at the...
  • Cervical Cancer
    Cervical cancer is cancer of the entrance to the womb (uterus). Regular pelvic exams and Pap testing can detectprecancerous...Some women also feel some pain similar to menstrual cramps. Your doctor...

AMENORRHEA


What is amenorrhea?

Amenorrhea is the medical term for the absence of menstrual periods, either on a permanent or temporary basis. Amenorrhea can be classified as primary or secondary. In primary amenorrhea, menstrual periods have never begun (by age 16), whereas secondary amenorrhea is defined as the absence of menstrual periods for three consecutive cycles or a time period of more than six months in a woman who was previously menstruating.
The menstrual cycle can be influenced by many internal factors such as transient changes in hormonal levels, stress, and illness, as well as external or environmental factors. Missing one menstrual period is rarely a sign of a serious problem or an underlying medical condition, but amenorrhea of longer duration may signal the presence of a disease or chronic condition.

What causes amenorrhea?

The normal menstrual cycle occurs because of changing levels of hormones made and secreted by the ovaries. The ovaries respond to hormonal signals from the pituitary gland located at the base of the brain, which is, in turn, controlled by hormones produced in the hypothalamus of the brain. Disorders that affect any component of this regulatory cycle can lead to amenorrhea. However, a common cause of amenorrhea in young females sometimes overlooked or misunderstood by the individual and others, is an undiagnosed pregnancy. Amenorrhea in pregnancy is a normal physiological function. Occasionally, the same underlying problem can cause or contribute to either primary or secondary amenorrhea. For example, hypothalamic problems, anorexia or extreme exercise can play a major role in causing amenorrhea depending on the age of the person and if she has experienced menarche.

Primary amenorrhea

Primary amenorrhea is typically the result of a genetic or anatomic condition in young females that never develop menstrual periods (by age 16) and is not pregnant. Many genetic conditions that are characterized by amenorrhea are conditions in which some or all of the normal internal female organs either fail to form normally during fetal development or fail to function properly. Diseases of the pituitary gland and hypothalamus (a region of the brain important for the control of hormone production) can also cause primary amenorrhea since these areas play a critical role in the regulation of ovarian hormones.
Gonadal dysgenesis is the name of a condition in which the ovaries are prematurely depleted of follicles and oocytes (egg cells) leading to premature failure of the ovaries. It is one of the most common cases of primary amenorrhea in young women.
Another genetic cause is Turner syndrome, in which women are lacking all or part of one of the two X chromosomes normally present in the female. In Turner syndrome, the ovaries are replaced by scar tissue and estrogenproduction is minimal, resulting in amenorrhea. Estrogen-induced maturation of the external female genitalia and sex characteristics also fails to occur in Turner syndrome.
Other conditions that may be causes of primary amenorrhea include androgen insensitivity (in which individuals have XY (male) chromosomes but do not develop the external characteristics of males due to a lack of response to testosterone and its effects), congenital adrenal hyperplasia, and polycystic ovary syndrome (PCOS).

Secondary amenorrhea

Pregnancy is an obvious cause of amenorrhea and is the most common reason for secondary amenorrhea. Further causes are varied and may include conditions that affect the ovaries, uterus, hypothalamus, or pituitary gland.
Hypothalamic amenorrhea is defined as amenorrhea that is due to a disruption in the regulator hormones produced by the hypothalamus in the brain. These hormones influence the pituitary gland, which in turn sends signals to the ovaries to produce the characteristic cyclic hormones. A number of conditions can affect the hypothalamus and lead to hypothalamic amenorrhea, such as:
  • extreme weight loss,
  • emotional or physical stress,
  • rigorous exercise, and
  • severe illness.
Other types of medical conditions can cause secondary amenorrhea:
  • tumors or other diseases of the pituitary gland that lead to elevated levels of the hormone prolactin (which is involved in milk production) also cause amenorrhea due to the elevated prolactin levels;
  • hypothyroidism;
  • elevated levels of androgens (male hormones), either from outside sources or from disorders that cause the body to produce too high levels of male hormones;
  • ovarian failure (premature ovarian failure or early menopause);
  • polycystic ovary syndrome; and
  • Asherman's syndrome is an example of uterine disease that causes amenorrhea. It results from scarring of the uterine lining following instrumentation (such as dilation and curettage) of the uterine cavity to manage postpartum bleeding or infection.

Post-pill amenorrhea

Women who have stopped taking oral contraceptive pills should experience the return of menstruation within three months after discontinuing pill use. Previously, it was believed that birth control pills increased a woman's risk of amenorrhea following use of the pill, but this has been proven not to be the case. Women who do not resume menstruation after three months have passed since oral contraceptive pills were stopped should be evaluated for causes of secondary amenorrhea.

PREGNANCY MATTER;S


PREGNANCY MATTERS

This clinical guideline concerns the management of hypertensive disorders inpregnancy and their complications from preconception to the postnatal period. For the purpose of this guideline, ‘pregnancy’ includes the antenatal, intrapartum and postpartum (6 weeks after birth) periods. The guideline has been developed with the aim of providing guidance in the following areas: information and advice for women who have chronic hypertension and are pregnant or planning to become pregnant; information and advice for women who are pregnant and at increased risk of developing hypertensive disorders of pregnancy; management of pregnancy with chronic hypertension; management of pregnancy in women with gestational hypertension; management of pregnancy for women with pre-eclampsia before admission to critical care level 2 setting; management of pre-eclampsia and its complications in a critical care setting; information, advice and support for women and healthcare professionals after discharge to primary care following a pregnancycomplicated by hypertension; care of the fetus during pregnancy complicated by a hypertensive disorder.
This clinical guideline contains recommendations for the management of diabetes and its complications in women who wish to conceive and those who are already pregnant. The guideline builds on existing clinical guidelines for routine care during the antenatal, intrapartum and postnatal periods. It focuses on areas where additional or different care should be offered to women with diabetes and their newborn babies.
The original antenatal care guideline was published by NICE in 2003. Since then a number of important pieces of evidence have become available, particularly concerning gestational diabetes, haemoglobinopathy and ultrasound, so that the update was initiated. This update has also provided an opportunity to look at a number of aspects of antenatal care: the development of a method to assess women for whom additional care is necessary (the ‘antenatal assessment tool’), information giving to women, lifestyle (vitamin D supplementation, alcohol consumption), screening for the baby (use of ultrasound for gestational age assessment and screening for fetal abnormalities, methods for determining normal fetal growth, placenta praevia), and screening for the mother (haemoglobinopathy screening, gestational diabetes, pre-eclampsia and preterm labour, chlamydia).
Bacterial vaginosis (BV) is the most common lower genital tract syndrome among women of reproductive age. This report will be used by the United States Preventive Services Task Force (USPSTF) to update its 2001 recommendation on screening and treatment for bacterial vaginosis in pregnancy. This update report will focus on three critical key questions related to screening, treatment, and adverse effects of screening and/or treatment on pregnancy outcomes in women asymptomatic for bacterial vaginosis at low, average, and high risk for preterm delivery.
Members of the US Preventive Services Task Force (USPSTF) defined the scope of this update, in cooperation with the Agency for Healthcare Research and quality (AHRQ) and the Oregon Evidence Based Practice Center (EPC) personnel. The Task Force's goals for this update were to address the gaps in the literature revealed in the 1996 USPSTF recommendations. These gaps related to the accuracy of risk assessment questionnaires in children with varying blood lead levels, the population prevalence at which to change from targeted screening to universal screening, the effectiveness of interventions to lower lead levels, and cost-effectiveness analyses of lead screening programs.
To update its 1996 guidelines, the U.S. Preventive Services Task Force (USPSTF) commissioned this brief update of the evidence on selected questions about screening for iron deficiency anemia (IDA) in children, adolescents, and pregnant women.
The review concluded that among women with foetal death in the second or third trimester, vaginal misoprostol was less effective than oral misoprostol at achieving uterine evacuation within 24 hours, but not within 48 hours. In view of the limitations of the evidence base, small sample sizes and heterogeneity between studies, the authors' conclusions may not be reliable.
The review assessed the safety of aspirin during pregnancy. The authors concluded that aspirin reduced the rate of pre-term deliveries, but not perinatal death, in women with moderate to high-risk pregnancies. The authors' conclusions seem appropriate. However, the lack of detail about the methodology of the review makes the reliability of the conclusions uncertain.
Women who have had a previous preterm birth are at increased risk of having another premature birth. Babies who are born before the 37th week of pregnancy, and particularly those born before the 34th week, are at greater risk of suffering problems at birth and of disability in childhood. 'Specialised' antenatal clinics have been suggested for women at high risk of a preterm birth as a way of improving health outcomes for the women and their infants. This review of three randomised controlled trials involving 3400 women in the USA found that there was no reduction in the number of preterm births in women attending specialised antenatal clinics. The results were difficult to interpret, as the trials were conducted in slightly different ways and offered slightly different care. The trials were all conducted in the 1980s, before the introduction of many of the screening tests currently offered in specialised antenatal clinics such as ultrasound assessment of cervical length. There was no information available on the effect of specialised antenatal care on maternal wellbeing or long‐term outcome.
Bibliographic details: Wang T, Liu SY, Xu LZ, Xing AY, Liu GJ.  Systematic review of effects for S-adenosyl-L-methionin on impROving the pregnancy outcomes of intrahepatic cholestasis of pregnancy.
We reviewed the evidence regarding the outcomes of interventions used in ovulation induction, superovulation, and in vitro fertilization (IVF) for the treatment of infertility. Short-term outcomes included pregnancy, live birth, multiple gestation, and complications. Long-term outcomes included pregnancy and post-pregnancycomplications for both mothers and infants.
This guideline has been developed to advise on the clinical management of and service provision for antenatal and postnatal mental health. The guideline recommendations have been developed after careful consideration of the best available evidence by a multidisciplinary team of healthcare professionals, women who have experienced mental health problems in the antenatal or postnatal period and guideline methodologists. It is intended that the guideline will be useful to clinicians and service commissioners in providing and planning high-quality care for women with antenatal and postnatal mental health problems while also emphasising the importance of the experience of care for women and their families and carers
Caesarean section (CS) is the end point of a number of care pathways hence it is not possible to cover all the clinical decisions and pathways which may lead to a CS in one guideline. This evidence based guideline has been developed to help ensure consistency of quality of care experienced by women having CS. It provides evidence based information for health care professionals and women about: the risks and benefits of CS; certain specific indications for CS; effective management strategies which avoid CS; anaesthetic and surgical aspects of care; interventions to reduce morbidity from CS; and aspects of organisation and environment which affect CS rates.
The aim of this guideline is to offer best practice advice on the care of people in the reproductive age group who perceive that they have problems in conceiving. Between 1998 and 2000, the Royal College of Obstetricians and Gynaecologists (RCOG) published three guidelines on the management of infertility that covered, respectively, initial investigation and management, management in secondary care and management in tertiary care. This guideline is based on those RCOG guidelines and takes into account a new review of the research evidence; it also covers the diagnostic, medical and surgical management of people throughout all stages of their care in primary-, secondary- and tertiary-care settings.
The use of bariatric surgery for treating severe obesity has increased dramatically over the past 10 years; about half of patients who undergo these procedures are women of reproductive age. This report was commissioned to measure the incidence of bariatric surgery in this population and review the evidence on the impact of bariatric surgery on fertility and subsequent pregnancy.
The RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center (RTI-UNC EPC) systematically reviewed evidence on outcomes of gestational weight gain and their confounders and effect modifiers, outcomes of weight gain within or outside the 1990 Institute of Medicine (IOM) guidelines, risks and benefits of weight gain recommendations, and anthropometric measures of weight gain.
“Don’t worry – the weight will just drop off quickly when you’re breastfeeding!” “Be careful – I never lost the weight after my second baby.” “Eat anything you want – you’re eating for two!” As with so many issues around pregnancy, it can seem as though everyone has an opinion about weight gain. It can be hard to find your way through all the competing advice. And comparing yourself to the magazine photos of movie stars in bikinis a few weeks after giving birth does not necessarily make real-life motherhood for the average woman any easier, either.
Many women who have asthma find that it actually improves in early pregnancy, or at least stays the same. But for about 1 in 3 women, the changes of pregnancy will make their asthma worse. Towards the end of pregnancy it often becomes increasingly difficult to stay physically active. Carrying the extra weight around can even make women who do not have asthma get out of breath. Many are unable to sleep properly, feel tired and exhausted. This does not make pregnancy any easier.
Using inhaled corticosteroids to control mild or moderate asthma in pregnancy can prevent asthma attacks and being hospitalised for asthma attacks in pregnancy. Inhaled budesonide has been tested particularly well in pregnancy and probably does not harm the baby.
Smoking during pregnancy increases the risk of the mother having complications during pregnancy and the baby being born too small (with low birthweight) and too early (prematurely, before 37 weeks). Low birthweight has been associated with coronary heart disease, type 2 diabetes, and being overweight in adulthood. Tobacco smoking also has serious long‐term health risks for both the women and their babies. Tobacco smoking during pregnancy is relatively common, although the trend is toward becoming less frequent in high‐income countries and more so in low to middle‐income countries. Many mothers find it hard to stop or reduce smoking during pregnancy even knowing the benefits of doing so as the nicotine in tobacco is very addictive. Smoking in pregnancy is also strongly associated with poverty, low levels of education, poor social support, depression and psychological illness.